Workforce Hospital Outcomes (in English Acute Hospitals)
Launched by UNIVERSITY OF SOUTHAMPTON · Apr 30, 2020
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
Note that for this study, "Study start" means the date the first hospital Trust was recruited. "Primary completion" is the date by which the investigators anticipate data analysis for the primary outcomes will be complete. "Study completion" is the data by which investigators anticipate data analysis for secondary outcomes will be complete.
The investigators cannot name the hospital Trusts participating because the investigators do not have their consent and this would breach GDPR.
Gender
ALL
Eligibility criteria
- Eligibility criteria for hospitals:
- • acute hospital Trust in England
- • willingness and ability to provide anonymised patient data and the ability to provide electronic roster data for a minimum period of 1 year prior to the commencement of the study.
- Eligibility criteria for patients:
- • stayed on at least one acute inpatient ward / admissions unit (including High Dependency Unit and Intensive Care Unit) during the study period.
About University Of Southampton
The University of Southampton is a leading research institution in the United Kingdom, renowned for its commitment to advancing medical and scientific knowledge. With a strong emphasis on innovation and interdisciplinary collaboration, the university conducts a wide range of clinical trials aimed at improving patient care and health outcomes. Its dedicated team of researchers and clinicians leverage cutting-edge technologies and methodologies to explore new treatments and interventions, contributing significantly to the field of healthcare. Through rigorous ethical standards and a focus on translational research, the University of Southampton strives to translate scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Peter Griffiths
Principal Investigator
The University of Southampton
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials